Banco Santander S.A. acquired a new stake in shares of Agilent Technologies, Inc. (NYSE:A – Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor acquired 6,621 shares of the medical research company’s stock, valued at approximately $1,141,000.
Other hedge funds also recently bought and sold shares of the company. State Street Corp lifted its stake in Agilent Technologies by 0.7% in the 2nd quarter. State Street Corp now owns 12,854,230 shares of the medical research company’s stock worth $1,710,658,000 after purchasing an additional 89,598 shares in the last quarter. Wellington Management Group LLP grew its holdings in Agilent Technologies by 2.7% in the 2nd quarter. Wellington Management Group LLP now owns 7,454,686 shares of the medical research company’s stock valued at $990,206,000 after buying an additional 198,253 shares in the last quarter. Deutsche Bank AG increased its stake in shares of Agilent Technologies by 17.1% in the 2nd quarter. Deutsche Bank AG now owns 7,008,634 shares of the medical research company’s stock worth $930,957,000 after acquiring an additional 1,024,516 shares during the last quarter. Bank of New York Mellon Corp increased its stake in shares of Agilent Technologies by 87.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 5,233,964 shares of the medical research company’s stock worth $695,227,000 after acquiring an additional 2,440,360 shares during the last quarter. Finally, Dimensional Fund Advisors LP raised its holdings in shares of Agilent Technologies by 9.6% during the 1st quarter. Dimensional Fund Advisors LP now owns 2,108,764 shares of the medical research company’s stock worth $240,336,000 after acquiring an additional 185,223 shares during the period.
Insiders Place Their Bets
In related news, Director Mikael Dolsten sold 634 shares of the company’s stock in a transaction dated Friday, September 4th. The shares were sold at an average price of $151.38, for a total value of $95,974.92. Following the sale, the director owned 4,924 shares of the company’s stock, valued at $745,395.12. The trade was a 11.41% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink.
Agilent Technologies Trading Down 0.9%
Agilent Technologies (NYSE:A – Get Free Report) last announced its quarterly earnings data on Wednesday, August 26th. The medical research company reported $1.62 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.49 by $0.13. The firm had revenue of $1.88 billion for the quarter, compared to analysts’ expectations of $1.84 billion. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%. Agilent Technologies’s revenue for the quarter was up 8.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.37 earnings per share. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Equities research analysts predict that Agilent Technologies, Inc. will post 6.20 EPS for the current fiscal year.
Agilent Technologies Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 27th. Investors of record on Tuesday, January 5th will be paid a $0.2625 dividend. The ex-dividend date is Tuesday, January 5th. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.2550. This represents a $1.05 dividend on an annualized basis and a dividend yield of 0.6%. Agilent Technologies’s dividend payout ratio is currently 20.08%.
Analysts Set New Price Targets
A number of analysts recently issued reports on the company. Wells Fargo & Company raised their price objective on Agilent Technologies from $160.00 to $180.00 and gave the stock an “overweight” rating in a research report on Friday, August 28th. Citigroup increased their target price on shares of Agilent Technologies from $185.00 to $190.00 and gave the stock a “buy” rating in a research note on Thursday, August 27th. Wall Street Zen upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research report on Saturday, October 17th. UBS Group boosted their price target on shares of Agilent Technologies from $165.00 to $180.00 in a research note on Tuesday, October 13th. Finally, HSBC upped their price objective on shares of Agilent Technologies from $165.00 to $175.00 and gave the stock a “buy” rating in a report on Tuesday, September 1st. Eighteen analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $181.45.
Get Our Latest Stock Report on A
About Agilent Technologies
Agilent Technologies develops and supplies instruments, software, services and consumables used in laboratories and manufacturing operations. Its offerings support applications in life sciences, diagnostics, chemical analysis, food safety, environmental testing and pharmaceutical research. The company serves customers worldwide, including pharmaceutical and biotechnology companies, clinical and academic laboratories, and organizations in the chemical, energy and food industries. Its services include laboratory equipment maintenance, technical support and related workflow solutions.
Further Reading
- Five stocks we like better than Agilent Technologies
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A – Free Report).
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
